Jean‐Louis Vildé

2.4k total citations
32 papers, 1.7k citations indexed

About

Jean‐Louis Vildé is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Jean‐Louis Vildé has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 10 papers in Infectious Diseases and 8 papers in Virology. Recurrent topics in Jean‐Louis Vildé's work include Pneumocystis jirovecii pneumonia detection and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (7 papers). Jean‐Louis Vildé is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (7 papers). Jean‐Louis Vildé collaborates with scholars based in France, United States and Vietnam. Jean‐Louis Vildé's co-authors include Catherine Leport, Benjamin J. Luft, Philippe Morlat, Jack S. Remington, Richard Hafner, Xavier Duval, Pascale Longuet, Guillaume Breton, Ann H. Korzun and Diana Antoniskis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Jean‐Louis Vildé

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Louis Vildé France 18 1.0k 556 513 372 250 32 1.7k
Philippe Morlat France 27 1.1k 1.1× 510 0.9× 1.4k 2.7× 1.0k 2.7× 95 0.4× 65 2.6k
F. Raffi France 21 734 0.7× 130 0.2× 721 1.4× 220 0.6× 87 0.3× 71 1.5k
John J. Stern United States 17 590 0.6× 102 0.2× 460 0.9× 184 0.5× 254 1.0× 38 1.3k
David Éverson Uip Brazil 21 638 0.6× 153 0.3× 336 0.7× 106 0.3× 187 0.7× 76 1.1k
Salvatore Casari Italy 26 750 0.7× 86 0.2× 807 1.6× 247 0.7× 122 0.5× 75 2.1k
Caterina Uberti‐Foppa Italy 22 1.0k 1.0× 71 0.1× 632 1.2× 328 0.9× 225 0.9× 109 1.7k
Ronald E. Keeney United States 21 1.4k 1.4× 148 0.3× 325 0.6× 127 0.3× 121 0.5× 36 1.8k
Raffaele Malinverni Switzerland 22 1.0k 1.0× 69 0.1× 648 1.3× 288 0.8× 157 0.6× 36 1.7k
C. Rapp France 18 289 0.3× 158 0.3× 508 1.0× 96 0.3× 95 0.4× 91 1.4k
Pompeyo Viciana Spain 31 1.1k 1.1× 165 0.3× 1.7k 3.3× 1.2k 3.2× 211 0.8× 131 2.9k

Countries citing papers authored by Jean‐Louis Vildé

Since Specialization
Citations

This map shows the geographic impact of Jean‐Louis Vildé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Louis Vildé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Louis Vildé more than expected).

Fields of papers citing papers by Jean‐Louis Vildé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Louis Vildé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Louis Vildé. The network helps show where Jean‐Louis Vildé may publish in the future.

Co-authorship network of co-authors of Jean‐Louis Vildé

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Louis Vildé. A scholar is included among the top collaborators of Jean‐Louis Vildé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Louis Vildé. Jean‐Louis Vildé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vildé, Jean‐Louis. (2015). L’obligation vaccinale en question. Tome 63(3). 8–23. 2 indexed citations
2.
Ecobichon, Jean-Luc, France Mentré, Agnès Certain, et al.. (2006). Consultation d’observance pour des malades infectés par le VIH et traités par antirétroviraux dans un service de maladies infectieuses et tropicales. La Presse Médicale. 35(9). 1241–1248. 5 indexed citations
3.
Lewden, Charlotte, Hélène Jacqmin‐Gadda, Jean‐Louis Vildé, et al.. (2004). An Example of Nonrandom Missing Data for Hepatitis C Virus Status in a Prognostic Study Among HIV-Infected Patients. HIV Clinical Trials. 5(4). 224–231. 5 indexed citations
4.
Breton, Guillaume, M. Alexandre, Xavier Duval, et al.. (2004). Tubulopathy Consecutive to Tenofovir-containing Antiretroviral Therapy in Two Patients Infected with Human Immunodeficiency Virus-1. Scandinavian Journal of Infectious Diseases. 36(6-7). 527–528. 21 indexed citations
5.
Chirgwin, Keith, Richard Hafner, Catherine Leport, et al.. (2002). Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study. Clinical Infectious Diseases. 34(9). 1243–1250. 68 indexed citations
6.
Martino, Vincent Di, Thierry Thévenot, Nathalie Boyer, et al.. (2002). Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 123(6). 1812–1822. 152 indexed citations
7.
8.
Hubert, Jean‐Baptiste, Élisabeth Dussaix, Catherine Tamalet, et al.. (2000). Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. AIDS. 14(2). 123–131. 165 indexed citations
9.
Salmon‐Céron, Dominique, Anne‐Marie Fillet, J Aboulker, et al.. (1999). Effect of a 14‐Day Course of Foscarnet on Cytomegalovirus (CMV) Blood Markers in a Randomized Study of Human Immunodeficiency Virus–Infected Patients with Persistent CMV Viremia. Clinical Infectious Diseases. 28(4). 901–905. 8 indexed citations
10.
Chêne, Geneviève, Philippe Morlat, Richard Hafner, et al.. (1998). Intention-to-Treat vs. On-Treatment Analyses of Clinical Trial Data. Controlled Clinical Trials. 19(3). 233–248. 39 indexed citations
11.
Anglaret, Xavier, François Dabis, J Batungwanayo, et al.. (1997). Chimioprophylaxie primaire de la tuberculose chez les personnes infectées par le VIH dans les pays non industrialisés. Cahiers d'études et de recherches francophones / Santé. 7(2). 89–94. 2 indexed citations
12.
Pueyo, Sophie, Louis‐Rachid Salmi, Geneviève Chêne, et al.. (1997). Survival After AIDS-Defining Events in Patients With<200 Lymphocytes CD4+ × 106/L Who Are Toxoplasmosis Antibody Positive. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(5). 459–464. 2 indexed citations
13.
Leport, Catherine, Philippe Morlat, Benjamin J. Luft, et al.. (1996). Pyrimethamine for Primary Prophylaxis of Toxoplasmic Encephalitis in Patients with Human Immunodeficiency Virus Infection: A Double-Blind, Randomized Trial. The Journal of Infectious Diseases. 173(1). 91–97. 53 indexed citations
14.
Mentec, Hervé, Catherine Leport, J Leport, et al.. (1994). Cytomegalovirus colitis in HIV-1-infected patients. AIDS. 8(4). 461–468. 38 indexed citations
15.
Luft, Benjamin J., Richard Hafner, Ann H. Korzun, et al.. (1993). Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 329(14). 995–1000. 293 indexed citations
16.
Dournon, E, et al.. (1992). Differences in the respiratory burst of human polymorphonuclear leukocytes induced by virulent and avirulent Legionella pneumophila Serogroup 1. Journal of Bioluminescence and Chemiluminescence. 7(2). 109–116. 2 indexed citations
17.
Molina, Jean‐Michel, et al.. (1991). Clinical and Bacterial Features of Infections Caused by Streptococcus milleri. Scandinavian Journal of Infectious Diseases. 23(6). 659–666. 64 indexed citations
18.
Salmon‐Céron, Dominique, et al.. (1989). Endocarditis due to pasteurella multocida with glomerulonephritis. The American Journal of Medicine. 86(4). 493–493. 16 indexed citations
19.
Crémieux, Anne‐Claude, S Witchitz, Michel Wolff, et al.. (1985). Clinical and echocardiographic observations in pulmonary valve endocarditis. The American Journal of Cardiology. 56(10). 610–613. 37 indexed citations
20.
Vildé, Jean‐Louis, J Breton-Gorius, Jacques Hakim, et al.. (1982). Congenital and Acquired Lactoferrin Deficiencies in Neutrophils. Advances in experimental medicine and biology. 611–620. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Morlat Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by John J. Stern Breakdown of academic impact, for papers by David Éverson Uip Breakdown of academic impact, for papers by Salvatore Casari Breakdown of academic impact, for papers by Caterina Uberti‐Foppa Breakdown of academic impact, for papers by Ronald E. Keeney Breakdown of academic impact, for papers by Raffaele Malinverni Breakdown of academic impact, for papers by C. Rapp Breakdown of academic impact, for papers by Pompeyo Viciana
Rankless by CCL
2026